People: Bausch Health Companies Inc (BHC.TO)

BHC.TO on Toronto Stock Exchange

8:37pm IST
Change (% chg)

$0.06 (+0.19%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Ackermann, Christina 

Ms. Christina Ackermann is Executive Vice President, General Counsel of the Company. She has been our Executive Vice President and General Counsel since August 2016. Prior to joining Bausch Health, Ms. Ackermann was part of the Novartis group of companies for the past 14 years, most recently serving as Senior Vice President, General Counsel for Alcon, where she was responsible for the Legal, Intellectual Property and Compliance functions. Prior to this, she served as Global Head, Legal and General Counsel at Sandoz, the generics division of Novartis, from 2007 to 2012. She joined Novartis Pharma in 2002 as Head, Legal Technical Operations and Ophthalmics and assumed the role of Head Legal General Medicine in July 2005. Before Novartis, Ms. Ackermann served in Associate General Counsel roles with Bristol Myers Squibb and DuPont Pharmaceuticals, as well as in private practice, where she focused on securities and mergers & acquisitions. Ms. Ackermann has a Post Graduate Diploma in EC Competition Law from King’s College, the University of London, U.K., a Bachelor of Laws from Queen’s University, Kingston, Canada, and attended York University, Toronto, Ontario, for her undergraduate studies in Math, Political Sciences and Fine Arts.

Basic Compensation

Total Annual Compensation, USD 647,539
Restricted Stock Award, USD 723,176
Long-Term Incentive Plans, USD --
All Other, USD 2,016,190
Fiscal Year Total, USD 3,386,910

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Joseph Papa


Paul Herendeen


Thomas Appio


Joseph Gordon


William Humphries


Mark McKenna

As Of  31 Dec 2018